Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Summit Therapeutics Inc., 3 years.
Summit Therapeutics Inc.
Director
Puma Biotechnology Inc
Director
Zymeworks Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Puma Biotechnology Inc June 11, 202698.8%
-
Summit Therapeutics Inc. June 12, 2025100.0%
-
Puma Biotechnology Inc June 11, 202574.5%
-
Puma Biotechnology Inc June 18, 202481.7%
-
Summit Therapeutics Inc. June 12, 202498.8%
-
Puma Biotechnology Inc June 13, 202398.0%
-
Summit Therapeutics Inc. May 23, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | Puma Biotechnology Inc | Option exercise | +50,000 | $2.93 | $146,500 |
| Sep 14, 2026 | Puma Biotechnology Inc | Open-market sale | −62,150 | $9.12 | $566,994 |
| Jun 11, 2026 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jul 18, 2025 | Puma Biotechnology Inc | Open-market sale | −27,000 | $3.37 | $90,990 |
| Jun 13, 2025 | Puma Biotechnology Inc | Open-market sale | −12,150 | $3.40 | $41,310 |
| Jun 11, 2025 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 18, 2024 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
| Jun 13, 2023 | Puma Biotechnology Inc | Grant or award | +27,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.